The global wellness industry is undergoing a paradigm shift, with Traditional Chinese Medicine (TCM) moving from the periphery to the mainstream of holistic health. As of 2024, the global market for herbal medicine and wellness products has exceeded $100 billion, with Chinese wellness manufacturers leading the charge. This growth is driven by a rising consumer preference for natural, preventative healthcare solutions and the rigorous scientific validation of ancient herbal wisdom.
From North American clinics to European pharmacies, the demand for high-purity TCM granules and specialized formulas is skyrocketing. Industrial-scale production in China now combines GAP-certified (Good Agricultural Practice) cultivation with advanced CO2 extraction and AI-driven quality control, ensuring that every batch meets the stringent safety standards required by global importers.
Neo-Green Herbs INC, the US subsidiary of Sichuan Neo-Green Pharmaceutical Technology Development Co., Ltd. (NGP), was founded in 2023. We inherit a millennial-long TCM culture, enhanced by modern technical expertise. We have served many regions around the world, including traditional Chinese medicine clinics, herbal extract wholesalers, medical institutions, and clinics. "We are committed to empowering global pharmacies through an efficient B2B supply chain to safeguard health."
Countries & Regions
Employees
Patent Applications
Planting Bases
Since 2002, NGP has pioneered the "Smart TCM Pharmacy" concept. Using AI algorithms to match herbal components and automated dispensing systems, we reduce human error and maximize therapeutic efficacy for global medical institutions.
Transitioning from raw decoction to high-concentrate granules involves low-temperature extraction technology. This preserves the "Sheng" (Life) of the herb while removing heavy metals and pesticides, meeting EU and US FDA guidelines.
The trend is shifting toward "Formula Customization." Our manufacturing capabilities allow for small-batch, patient-specific formula production, delivered directly to clinics worldwide through our robust supply chain.
We implement a New Circular Economy of Traditional Chinese Medicine, integrating planting, extraction, and environmental protection by recycling herbal dregs into organic fertilizer for our own GAP bases.
Founded in 2009, Sichuan Neo-Green Pharmaceutical Technology Development Co., Ltd (NGP) is a comprehensive TCM enterprise. With total assets of more than 30 billion RMB, we are a "National Key Leading Enterprise in Agricultural Industrialization." We don't just export products; we export a sustainable healthcare ecosystem.
Our marketing network is nationwide and expanding globally, leveraging e-commerce and social media to increase brand awareness. We adhere to a "people-oriented, service first" concept, ensuring that practitioners in North America, Europe, and Southeast Asia have 24/7 access to our medical consultation and logistical support.
Our Quality Assurance team employs advanced testing equipment and methodologies to monitor all stages of production, guaranteeing the authenticity, potency, purity, and consistency of our herbal medicines. We continuously invest in R&D to innovate while preserving the integrity of ancient TCM practices.
We will gather more enterprise advantage to provide innovative products with high quality and excellent service, to keep our long-term friendship. Provide comprehensive and high-quality pharmaceutical supply chain solutions for traditional Chinese medicine practitioners and clinics worldwide.
Contact Us Now
NGP intends to invest in more than 300 production bases across China, including Jiangxi, Yunnan, and Chongqing. This vertical integration ensures that we control quality from the seed to the shelf.
NGP has built a worldwide sales network. Our core products occupy an important position in domestic and overseas markets, consistently improving brand influence through clinical success.
We actively fulfill our social responsibility, participating in public welfare and environmental protection, demonstrating the ethics of a leader in the bio-pharmaceutical industry.